Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Nankivell

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 17, 2012
Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patientsNeal Navani, James M Brown, Matthew Nankivell, et al.
Lancet (London, England)|May 24, 2015
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trialSean Kehoe, Jane Hook, Matthew Nankivell, et al.
Thorax|August 5, 2011
Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre studyNeal Navani, Philip L Molyneaux, Ronan A Breen, et al.
The Lancet. Oncology|August 9, 2017
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trialDerek Alderson, David Cunningham, Matthew Nankivell, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screeningShengqing Gu, Stephanie Lheureux, Azin Sayad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy TrialElizabeth C Smyth, Matteo Fassan, David Cunningham, et al.
Oncotarget|October 22, 2016
Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trialMatthew D Hale, Matthew Nankivell, Gordon G Hutchins, et al.
The Lancet. Oncology|January 22, 2013
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trialDan Stark, Matthew Nankivell, Eric Pujade-Lauraine, et al.
Lancet (London, England)|May 20, 2008
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialMartin F Muers, Richard J Stephens, Patricia Fisher, et al.
Chest|May 20, 2020
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung CancerFabio Perrotta, Matthew Nankivell, Jana B Adizie, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
American Journal of Respiratory and Critical Care Medicine|April 17, 2012
Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patientsNeal Navani, James M Brown, Matthew Nankivell, et al.
Lancet (London, England)|May 24, 2015
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trialSean Kehoe, Jane Hook, Matthew Nankivell, et al.
Thorax|August 5, 2011
Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre studyNeal Navani, Philip L Molyneaux, Ronan A Breen, et al.
The Lancet. Oncology|August 9, 2017
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trialDerek Alderson, David Cunningham, Matthew Nankivell, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2021
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screeningShengqing Gu, Stephanie Lheureux, Azin Sayad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2016
Effect of Pathologic Tumor Response and Nodal Status on Survival in the Medical Research Council Adjuvant Gastric Infusional Chemotherapy TrialElizabeth C Smyth, Matteo Fassan, David Cunningham, et al.
Oncotarget|October 22, 2016
Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trialMatthew D Hale, Matthew Nankivell, Gordon G Hutchins, et al.
The Lancet. Oncology|January 22, 2013
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trialDan Stark, Matthew Nankivell, Eric Pujade-Lauraine, et al.
Lancet (London, England)|May 20, 2008
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trialMartin F Muers, Richard J Stephens, Patricia Fisher, et al.
Chest|May 20, 2020
Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung CancerFabio Perrotta, Matthew Nankivell, Jana B Adizie, et al.
Pageof 5